Alvarez L, Entrocasso C, Lifschitz A, Manazza J, Ceballos L, Borda B, Lanusse C
Laboratorio de Farmacología, Departamento de Fisiopatología, Facultad de Ciencias Veterinarias, UNCPBA, Campus Universitario, (7000), Tandil, Argentina and CONICET, Argentina.
J Parasitol. 2010 Dec;96(6):1204-10. doi: 10.1645/GE-2524.1. Epub 2010 Jul 20.
Enhanced plasma availability of albendazole sulphoxide (ABZSO), the active metabolite of albendazole (ABZ), has been described in feed-restricted sheep. The aim of the present work was to determine if the absorption-related pharmacokinetic changes derived from fasting animals prior to drug treatment would modify the clinical efficacy of ABZ against resistant gastrointestinal nematodes in lambs. Forty Corriedale lambs, naturally infected with resistant gastrointestinal nematodes, were divided into 4 groups. Controls were fed ad libitum and did not receive any drug treatment. Treated animals were fed ad libitum up to 30 min prior to treatment with ABZ (3.8 mg/kg) by the intraruminal route. The control (fasted) animals were not fed during the 24-hr period prior to the start of the experiment and did not receive any drug treatment. A second treated group of animals were fasted 24 hr prior to the treatment with ABZ, as previously described for the fed-treated group. Blood samples were collected over a period of 72 hr post-treatment from 6 animals in each treated group. Plasma samples were analyzed by high performance liquid chromatography. The pharmacokinetic parameters were statistically compared using parametric statistical tests. The estimation of the efficacy of the different treatments was performed by the fecal egg count reduction test (FECRT). Additionally, 4 animals randomly chosen from the control-fed and treated groups were killed 13 days post-treatment to evaluate the efficacy against different adult nematode parasites. The results were statistically compared by parametric and non-parametric tests. Significantly (P < 0.05) higher Cmax and AUC values were observed for both the ABZSO and ABZ-sulphone (ABZSO(2)) metabolites in the fasted compared to the fed animals. These kinetic results may be due to a fasting-induced delay in the GI transit time which increases ABZ dissolution and GI absorption. However, a poor ABZ efficacy (measured as FECRT), compatible with a high degree of nematode resistance, was obtained in both fed (48%) and fasted (49%) animals. Haemonchus contortus and Trichostrongylus colubriformis appeared as the more reluctant species with respect to ABZ treatment. The efficacy against H. contortus ranged between 37 (fed) and 54% (fasted) and against T. colubriformis between 0% (fed) and 16% (fasted). Under these experimental conditions, the fasting-induced improvement on ABZ systemic availability (>60%) did not improve its activity against nematodes with a high degree of resistance. However, the data described here for a highly resistant nematode population should not discourage the use of fasting as a practical and well-proven management tool for parasite control in ruminants.
在限饲绵羊中,已观察到阿苯达唑(ABZ)的活性代谢产物阿苯达唑亚砜(ABZSO)的血浆可用性增强。本研究的目的是确定药物治疗前禁食动物引起的与吸收相关的药代动力学变化是否会改变ABZ对羔羊抗药胃肠道线虫的临床疗效。40只自然感染抗药胃肠道线虫的考力代羔羊被分为4组。对照组自由采食,未接受任何药物治疗。治疗组动物在通过瘤胃途径给予ABZ(3.8mg/kg)治疗前30分钟自由采食。对照(禁食)组动物在实验开始前24小时内未进食,也未接受任何药物治疗。第二组治疗组动物在给予ABZ治疗前禁食24小时,如前所述的采食治疗组。治疗后72小时内从每个治疗组的6只动物采集血样。血浆样品通过高效液相色谱法分析。使用参数统计检验对药代动力学参数进行统计学比较。通过粪便虫卵计数减少试验(FECRT)评估不同治疗方法的疗效。此外,在治疗后13天随机从对照采食组和治疗组中选择4只动物处死,以评估对不同成虫线虫寄生虫的疗效。结果通过参数和非参数检验进行统计学比较。与采食动物相比,禁食动物的ABZSO和阿苯达唑砜(ABZSO(2))代谢产物的Cmax和AUC值均显著(P<0.05)升高。这些动力学结果可能是由于禁食引起的胃肠道转运时间延迟,从而增加了ABZ的溶解和胃肠道吸收。然而,采食(48%)和禁食(49%)动物的ABZ疗效均较差(以FECRT衡量),这与高度的线虫抗性相符。捻转血矛线虫和蛇形毛圆线虫似乎是对ABZ治疗最不敏感的物种。对捻转血矛线虫的疗效在采食组为37%,禁食组为54%;对蛇形毛圆线虫的疗效在采食组为0%,禁食组为16%。在这些实验条件下,禁食引起的ABZ全身可用性提高(>60%)并未改善其对高度抗性线虫的活性。然而,这里描述的针对高度抗性线虫群体的数据不应阻碍将禁食作为反刍动物寄生虫控制的一种实用且经过充分验证的管理工具。